Brief: Otsuka Pharmaceutical And H. Lundbeck Say U.S. FDA Accepted New Drug Application For Aripiprazole Injectable To Treat Adult Schizophrenia And Bipolar I Disorder

H Lundbeck A/S

13/09/2022 07:27

Sept 13 (Reuters) - 
    * OTSUKA PHARMACEUTICAL AND H. LUNDBECK SAY U.S. FDA
ACCEPTED NEW
DRUG APPLICATION FOR ARIPIPRAZOLE INJECTABLE TO TREAT ADULT
SCHIZOPHRENIA AND BIPOLAR I DISORDER

Further company coverage:  4578.T 

 (Reporting by Tokyo Newsroom)
 ((+81345201189;))